Is docetaxel now an essential component of neoadjuvant breast chemotherapy?

J Clin Oncol. 2004 May 1;22(9):1766; author reply 1766-7. doi: 10.1200/JCO.2004.99.341.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Clinical Trials, Phase III as Topic
  • Cyclophosphamide / administration & dosage
  • Docetaxel
  • Doxorubicin / administration & dosage
  • Endpoint Determination
  • Female
  • Humans
  • Neoadjuvant Therapy
  • Reproducibility of Results
  • Survival Analysis
  • Taxoids / administration & dosage
  • Taxoids / therapeutic use*

Substances

  • Taxoids
  • Docetaxel
  • Doxorubicin
  • Cyclophosphamide